VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 135 filers reported holding VIKING THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $8,000 | -33.3% | 2,500 | 0.0% | 0.00% | -33.3% |
Q4 2021 | $12,000 | -25.0% | 2,500 | 0.0% | 0.00% | -40.0% |
Q3 2021 | $16,000 | +6.7% | 2,500 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $15,000 | -6.2% | 2,500 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $16,000 | +14.3% | 2,500 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $14,000 | – | 2,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |